EMBARK, a Phase 3 Trial Evaluating Safety and Efficacy of Delandistrogene Moxeparvovec (SRP- 9001) in Duchenne Muscular Dystrophy (DMD): Study Design and Baseline Characteristics (P5-8.012)

Autor:	Francesco Muntoni, Eugenio Mercuri, Ulrike Schara Schmidt, Hirofumi Komaki, James Richardson, Tejdip Singh, Maitea Guridi, Stefanie Mason, Alex Murphy, Lixi Yu, Carol Reid, Eddie Darton, Christoph Wandel, Jerry Mendell
Rok vydání:	2023
Zdroj:	Monday, April 24.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::aabb3e2264ff43cdfdd694f0d140ea1b https://doi.org/10.1212/wnl.0000000000203455 Zobrazit plný text záznamu